Clik here to view.
Johnson & Johnson, Texas Medical Center launch medical device accelerator
Johnson & Johnson (NYSE:JNJ) said today that its J&J Innovation subsidiary and Houston’s Texas Medical Center are launching a medical technology accelerator called the Center for Device...
View ArticleClik here to view.
St. Jude Medical launches pediatric trial for Amplatzer Duct Occluder II AS...
St. Jude Medical (NYSE:STJ) said today that it’s launching a pediatric clinical trial of a version of its Amplatzer cardiac implant for treating a congenital heart defect. The 50-patient ADO II AS...
View ArticleClik here to view.
Boston Scientific launches Resolution 360 hemostasis clip
Boston Scientific (NYSE:BSX) said today that it launched its Resolution 360 hemostasis clip, designed to provide physicians with controlled rotation for more accurate clip placement during endoscopy...
View ArticleClik here to view.
Orthocell wins ethics nod for CelGro trial in peripheral nerve regeneration
Orthocell (ASX:OCC) said today that it won ethics approval for a human study evaluating its CelGro collagen soft tissue repair device for peripheral nerve regeneration. The study is slated to enroll 20...
View ArticleClik here to view.
Vascular Solutions bids for FDA nod for RePlas freeze-dried plasma
Vascular Solutions (NSDQ:VASC) said today that it filed an investigational new drug application with the FDA for the RePlas freeze-dried plasma product it’s developing with the U.S. Army Medical...
View ArticleClik here to view.
FDA awards product development grants for rare diseases
The FDA said yesterday that it awarded 21 clinical trial research grants totaling more than $23 million over the next 4 years to stimulate product development for patients with rare diseases. The...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for October 18, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
SteadyMed details commercialization plans for Trevyent
SteadyMed Therapeutics (NSDQ:STDY) today detailed the development of its lead drug product candidate, Trevyent (treprostinil sodium), for the treatment of pulmonary arterial hypertension using its...
View ArticleClik here to view.
JNJ’s Ethicon launches Harmonic HD 1000i surgical shears
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon said today it launched its high-precision Harmonic HD 1000i surgical shears, which are designed for procedures involving complex thoracic,...
View ArticleClik here to view.
Outpatient care quality stays flat
(Reuters) — The quality of outpatient care hasn’t changed much in the U.S. over the past decade, despite a variety of local, regional and national efforts to encourage improvements, a study suggests....
View ArticleClik here to view.
Fitness tracker accuracy varies when it comes to the heart
(Reuters) — Commercial fitness trackers worn on the wrist are less accurate than a chest strap monitor at measuring heart rate, and may over- or underestimate heart rate depending on activity level,...
View ArticleClik here to view.
Keystone Nano wins orphan designation for ceramide liver cancer treatment
Keystone Nano said today that its ceramide nanoliposome won orphan drug status for the treatment of liver cancer. The designation provides the company with a window of market exclusivity upon product...
View ArticleClik here to view.
Intuitive Surgical’s Q3 numbers smash estimates
Third-quarter financial numbers for Intuitive Surgical (NSDQ:ISRG) smashed Wall Street’s forecast, coming in at more than a dollar above the consensus earnings estimate on sales growth of nearly 16%....
View ArticleClik here to view.
Boston Scientific wants Supreme Court to toss $309m patent loss to ICD...
Boston Scientific (NYSE:BSX) asked the U.S. Supreme Court this month to toss a Maryland state court decision over cardiac rhythm management device patents that awarded more than $309 million to the...
View ArticleClik here to view.
St. Jude Medical misses with Q3 results
Shares in St. Jude Medical (NYSE:STJ) are under pressure pre-market today after the medical device giant posted 3rd-quarter earnings that missed expectations on Wall Street. Little Canada, Minn.-based...
View ArticleClik here to view.
Short-seller Muddy Waters floats more videos claiming cybersecurity risks...
In a release timed to coincide with St. Jude Medical‘s (NYSE:STJ) 3rd-quarter results announcement today, short-selling firm Muddy Waters posted a series of videos purporting to show cybersecurity...
View ArticleClik here to view.
Abbott’s Q3 results beat The Street despite surprise swing to red ink on...
Abbott (NYSE:ABT) beat expectations on Wall Street today with its 3rd-quarter earnings, despite putting red ink in the ledger thanks to its 13% stake in beleaguered pharma giant Mylan (NSDQ:MYL). The...
View ArticleClik here to view.
Turning cynicism into healthy skepticism between clinicians and industry
A former practicing cardiologist, Boston Scientific (NYSE:BSX) executive Dr. Ken Stein has experienced firsthand the cynicism between clinicians and the industry. As an example, Stein cites the issue...
View ArticleClik here to view.
Quark Venture, China’s GF Securities launch $500m life sciences fund
Quark Venture Inc. and GF Securities said this week that they’re launching a $500 million global health sciences venture fund based in Vancouver. The fund is the largest of its kind in Canada and will...
View ArticleClik here to view.
Belarus software engineer builds cheap, open-source prosthetic arm in basement
Oleg Galtsev, a 32-year-old software engineer, developed a cheap, open-source prosthetic arm in his Belarus basement for his father, Sergei Galtsev, a former Soviet army captain who lost his right arm...
View Article